Atherosclerosis, the underlying cause of myocardial infarction and stroke, is a lipid-driven chronic inflammatory disease characterized by lipoprotein and leukocyte accumulation in the vessel wall. Among leukocytes, monocyte-derived intimal macrophages are arguably the most decisive contributors to the development, progression, exacerbation, and regression of atherosclerosis. As key effectors of inflammation, proteolysis, oxidative stress, lipid clearance, and efferocytosis, macrophages have long been therapeutic targets for the treatment of atherosclerosis. However, macrophage content in the vessel wall is highly dynamic, relying on multiple systemic and local processes that are governed by distinct biological pathways. Recently, we showed that psychosocial stress, which potentiates cardiovascular disease (CVD), aggravates atherosclerosis by disturbing the macrophage supply chain; animals subjected to intermittent psychosocial stress developed inflamed lesions containing more numerous macrophages than controls. In this project, we will ask how stress affects mechanisms related to influx of monocytes (medullary myelopoiesis, mobilization of monocytes and stem cells, extramedullary myelopoiesis, and monocyte influx to lesions), macrophage accrual in lesions (macrophage differentiation and local proliferation), and macrophage efflux (macrophage death through apoptosis, necrosis, or secondary necrosis, and macrophage emigration). Collectively, we refer to these as macrophage dynamics. We will investigate the impact of stress on macrophage dynamics in the progression and regression of atherosclerosis, with specific focus on the sympathetic nervous system and neuronal guidance cues. We will identify the decision nodes that control processes related to macrophage dynamics with the ultimate aim of targeting them therapeutically.
Social stress is a risk factor for atherosclerotic disease. Macrophages are key cells in the progression and regression of atherosclerosis. This proposal will investigate how social stress affects macrophage dynamics in atherosclerosis.
| Seijkens, Tom T P; van Tiel, Claudia M; Kusters, Pascal J H et al. (2018) Targeting CD40-Induced TRAF6 Signaling in Macrophages Reduces Atherosclerosis. J Am Coll Cardiol 71:527-542 |
| Ishai, Amorina; Osborne, Michael T; Tung, Brian et al. (2018) Amygdalar Metabolic Activity Independently Associates with Progression of Visceral Adiposity. J Clin Endocrinol Metab : |
| Braza, Mounia S; van Leent, Mandy M T; Lameijer, Marnix et al. (2018) Inhibiting Inflammation with Myeloid Cell-Specific Nanobiologics Promotes Organ Transplant Acceptance. Immunity 49:819-828.e6 |
| Fayad, Zahi A; Swirski, Filip K; Calcagno, Claudia et al. (2018) Monocyte and Macrophage Dynamics in the Cardiovascular System: JACC Macrophage in CVD Series (Part 3). J Am Coll Cardiol 72:2198-2212 |
| Braza, Mounia S; Conde, Patricia; Garcia, Mercedes et al. (2018) Neutrophil derived CSF1 induces macrophage polarization and promotes transplantation tolerance. Am J Transplant 18:1247-1255 |
| Duivenvoorden, Raphaël; Mulder, Willem J M (2018) Imaging Tropoelastin in Atherosclerosis. Circ Cardiovasc Imaging 11:e008147 |
| Senders, Max L; Mulder, Willem J M (2018) Targeting myeloperoxidase in inflammatory atherosclerosis. Eur Heart J 39:3311-3313 |
| Senders, Max L; Hernot, Sophie; Carlucci, Giuseppe et al. (2018) Nanobody-Facilitated Multiparametric PET/MRI Phenotyping of Atherosclerosis. JACC Cardiovasc Imaging : |
| Senders, Max L; Que, Xuchu; Cho, Young Seok et al. (2018) PET/MR Imaging of Malondialdehyde-Acetaldehyde Epitopes With a Human Antibody Detects Clinically Relevant Atherothrombosis. J Am Coll Cardiol 71:321-335 |
| Tawakol, Ahmed; Ishai, Amorina; Takx, Richard Ap et al. (2017) Relation between resting amygdalar activity and cardiovascular events: a longitudinal and cohort study. Lancet 389:834-845 |
Showing the most recent 10 out of 24 publications
